Purchase Order 75D30119P06349
Award Date 8/19/19
Potential Completion Date 8/18/20
Potential Value $110K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This SBIR Phase I contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $150,000.00 firm fixed price purchase order is for the company's high throughput protein microarray technology and related services. Immport Therapeutics has provided these products and services to support the CDC's detection and response efforts for pathogens such as monkeypox virus, Brucella,...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Immport Therapeutics Inc., doing business as Antigen Discovery Inc., for $30,000.00. The contract is for the provision of microarray products and services to support detection and response efforts related to pathogens such as monkeypox virus, Brucella, SARS-CoV-2, and Leptospirosis. Immport Therapeutics is a biotechnology company specializing in high throughput...
- This is a $5,680 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for the analysis of protein samples, which supports NIAID's mission in infectious disease research and response. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract, valued at $15,000.00, is for the provision of falciparum custom protein microarrays. Immport Therapeutics is a biotechnology company that specializes in high-throughput protein microarray technology and related services, and has...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Abclonal Science, Inc. (doing business as Abclonal Technology), a foreign-owned, self-certified small disadvantaged business. The $246,880.00 firm-fixed-price purchase order is for gene synthesis antibodies, with a completion date of August 30, 2020. The contract does not have a set-aside designation. Based on the agency and description, this contract...
- This federal contract award to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, is for the provision of HIR MSD ANTIBODIES AND PANEL KITS. The $135,271.04 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract does not have a set-aside designation and has an ultimate completion date of September 30, 2024. Meso Scale Diagnostics is a provider of assay development services, laboratory testing equipment,...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
- Agena Bioscience, Inc. has been awarded a firm fixed price purchase order valued at twenty-two thousand five hundred fifty-five dollars ($22,555) by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of Agena Bioscience IPLEX Pro Genotyping Kits to the CDC facility in San Diego, California, with performance taking place between September 7-15, 2023. No subcontractors or set aside designations were indicated. The genotyping...
- This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a for-profit manufacturer of biomedical research and genetic analysis tools. The $160,678.75 firm fixed price purchase order is for the delivery of INTELLIFLEX EQUIPMENT with a completion date of August 31, 2022. The contract has no set-aside designation. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation,...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $256,725 firm fixed price purchase order to Element Biosciences, Inc., a small disadvantaged business manufacturer of genetic analysis equipment and tools, for the delivery of an AVITI System next-generation DNA sequencing platform. The contract has a performance period ending on September 30, 2024 and does not utilize a small business set-aside. This award represents one of several federal contracts received by Element...